← Back to Search

Behavioral Intervention

Follow-Up Scheduling for ER Patients

N/A
Recruiting
Led By Amir Goren, PhD
Research Sponsored by Geisinger Clinic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
>= 18 years of age
ED visit rated as high acuity (level L2 or L3)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up within 60 days following day of discharge
Awards & highlights

Summary

"This trial aims to reduce unnecessary visits to the emergency department by encouraging patients with high acuity visits to follow up with their primary care provider or specialist for appropriate care. Patients will either receive or not receive

Who is the study for?
This trial is for patients who have had a high-acuity visit to the emergency department (ED). It's designed to see if follow-up reminders can help them get appropriate care outside of the ED. To participate, individuals must be able to receive text messages and use hyperlinks.
What is being tested?
The study tests whether sending a text message with information on scheduling a follow-up appointment with primary care or specialists after an ED visit reduces unnecessary future ED visits. Some will receive this outreach; others won't, to compare outcomes.
What are the potential side effects?
There are no medical side effects associated with this intervention as it involves receiving informational text messages and using self-scheduling tools rather than taking medication or undergoing procedures.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18 years old or older.
Select...
My last ER visit was for a very urgent issue.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~within 60 days following day of discharge
This trial's timeline: 3 weeks for screening, Varies for treatment, and within 60 days following day of discharge for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Return to ED
Other outcome measures
PCP/specialist appointment attended
PCP/specialist appointment scheduled

Trial Design

3Treatment groups
Experimental Treatment
Active Control
Group I: Experimental: Schedule Follow-Up Visit - 2 messagesExperimental Treatment1 Intervention
This arm will receive text messages (at 1 day and 8 days post-ED discharge) and information added to the patient's after visit summary providing a number and patient portal hyperlink via which to schedule an ED follow-up appointment.
Group II: Experimental: Schedule Follow-Up Visit - 1 messageExperimental Treatment1 Intervention
This arm will receive a text message (at 1 day post-ED discharge) and information added to the patient's after visit summary providing a number and patient portal hyperlink via which to schedule an ED follow-up appointment.
Group III: ControlActive Control1 Intervention
This arm will receive no intervention outside of usual care.

Find a Location

Who is running the clinical trial?

Geisinger ClinicLead Sponsor
153 Previous Clinical Trials
1,974,155 Total Patients Enrolled
Amir Goren, PhDPrincipal InvestigatorGeisinger Clinic
21 Previous Clinical Trials
529,607 Total Patients Enrolled
~1 spots leftby Feb 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top